Literature DB >> 12580370

Malignant abdominal masses in children: quick guide to evaluation and diagnosis.

Carla B Golden1, James H Feusner.   

Abstract

A palpable mass in the abdomen of a child is a serious finding. In this article the authors present their single-institution experience of how these malignancies present and their distribution by age and diagnosis. The most common abdominal malignancies diagnosed in the pediatric population include neuroblastoma, Wilms' tumor, hepatoblastoma, lymphoma, and germ cell tumors. This article provides the busy general pediatrician with some guidelines of how to proceed after discovering a suspiciousmass.

Entities:  

Mesh:

Year:  2002        PMID: 12580370     DOI: 10.1016/s0031-3955(02)00098-6

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  5 in total

1.  [Imaging of abdominal tumors in childhood and adolescence : Part I: Background, hepatic, splenic and pancreatic tumors].

Authors:  D M Renz; H-J Mentzel
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

2.  Sudden death due to adrenal neuroblastoma: child abuse mimic?

Authors:  Ko Un Park; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2010-09-21       Impact factor: 2.007

3.  Surgical Management of Giant L2 Adrenal Neuroblastoma in Adult Male.

Authors:  Bikash Bikram Thapa; Sanjay Yadav; Sujit Pant; Pratik Rajkarnikar; Pankaj Mandal
Journal:  Case Rep Urol       Date:  2020-12-05

Review 4.  Imaging findings of gastrointestinal tract tumors in children and adolescents.

Authors:  H Nursun Özcan; Özlem Özkale Yavuz; Saniye Ekinci; Berna Oguz; Tezer Kutluk; Mithat Haliloglu
Journal:  Insights Imaging       Date:  2022-03-22

Review 5.  Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions.

Authors:  Till-Martin Theilen; Yannick Braun; Konrad Bochennek; Udo Rolle; Henning C Fiegel; Florian Friedmacher
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.